Opportunistic infections complicating immunotherapy for non‐small cell lung cancer

Immunotherapy has produced durable responses in numerous advanced and metastatic cancers, especially advanced non‐small cell lung carcinoma (NSCLC). However, opportunistic infection has become a major risk for patients who have received immune checkpoint inhibitors (ICIs). Early diagnosis of infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ziwei, Liu, Tao, Zhang, Xiaotong, Si, Xiaoyan, Wang, Hanping, Zhang, Jingjia, Huang, Hui, Sun, Xuefeng, Wang, Jinglan, Wang, Mengzhao, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262884/
https://www.ncbi.nlm.nih.gov/pubmed/32311221
http://dx.doi.org/10.1111/1759-7714.13422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262884/
https://www.ncbi.nlm.nih.gov/pubmed/32311221
http://dx.doi.org/10.1111/1759-7714.13422

Ejemplares similares